Clinical Trials

We partner with pharmaceutical companies around the world to provide the latest advances in medications, treatment and procedures at no cost to our patients, including:

  • Ultrasounds
  • Fibro Scan
  • Liver MRI-PDFF
  • DEXA
  • Liver Biopsy
  • We provide our patients with tools to engage in lifestyle changes through personalized counseling to help them gain the knowledge, skills, and confidence to drive diabetes and other metabolic disorders.

    Southwest General Healthcare Center has supported research to advance several classes of drugs and device medically relevant to:

  • NAFLD/NASH
  • Liver Cirrhosis
  • Obesity
  • Enroll on our Upcoming Studies

    Nash

    Participants must be:

  • Male or non-pregnant female participants between 18 to 75 years
  • Overweight/obese subjects with body mass index (BMI) ≥ 25 kg/m2
  • Female subjects must be non-pregnant and non-lactating.
  • Fibrosis Stage 4

    Participants must be:

  • Male or non-pregnant female participants between 18 to 75 years
  • Previous history or presence of Type 2 Diabetes.
  • A liver biopsy must be performed at Screening.
  • COPD

    Participants Must Be:

  • Male or non-pregnant female participants between 40 to 75 years,
  • Current or ex-smokers,
  • Able to perform spirometry.
  • Diabetes Mellitus Type 2

    Participants Must Be:

  • Male or non-pregnant female participants between 18 to 65 years,
  • BMI ≥25 and ≤40 kg/m2,
  • Diagnosed with Diabetes mellitus Type 2 within the last 15 years.
  • Cushing's Syndrome

    Participants Must Be:

  • Male or non-pregnant female participants aged 18 or older.
  • Documented diagnosis of ACTH-dependent Cushing’s syndrome.
  • Current evidence of Cushing’s morbidities of hyperglycemia, dyslipidemia,hypertension, or osteopenia.
  • Hypercortisolism Related to a Benign Adrenal Tumor

    Participants Must Be:

  • Male or non-pregnant female participants aged 18 or older,
  • Diagnosed with T2DM,
  • Documented characteristically benign adrenal nodule(s), either unilateral or bilateral with maximum individual diameter ≤ 4 cm, homogenous texture, and non-contrast computerized tomography ≤ 20 HU attenuation or proven to be nonmalignant.
  • Diabetic with Fatty Liver

    Participants Must Be:

  • Male or non-pregnant female participants between 18 to 70 years,
  • BMI ≥25 and ≤40 kg/m2,
  • Diabetes mellitus Type 2.
  • Nonalcoholic Steatohepatitis

    Participants Must Be:

  • Male or non-pregnant female participants between 18 to 80 years,
  • A liver biopsy must be performed at Screening.
  • Have a Question or Comment?

    Southwest General Healthcare Center 29 Barkley Circle Fort Myers, FL 33907

    Please enter your email, so we can follow up with you.